Literature DB >> 19374275

Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia.

Julia M L Brotherton1, Shelley L Deeks, Sue Campbell-Lloyd, Avner Misrachi, Irene Passaris, Karen Peterson, Helen Pitcher, Megan Scully, Maureen Watson, Rosalind Webby.   

Abstract

In November 2006, the Australian Government announced the National HPV Vaccination Program, consisting of a course of prophylactic human papillomavirus (HPV) vaccine for all Australian females aged 12-26 years. Females aged 12-18 years are vaccinated through school-based programs. The school-based component commenced in April 2007, with the school years targeted varying across jurisdictions. Each jurisdiction maintains comprehensive records of HPV doses delivered in the school-based programs although how this is captured varies. This report presents interim coverage estimates for Year 1 (2007) of the program. Both New South Wales and Victoria achieved coverage of 70% or more among almost all school cohorts vaccinated in the program. Some of the variation in coverage achieved may reflect different levels of experience with school-based programs, and varying methods for school-based vaccine delivery and recording of doses administered. Except for some doses in South Australia, these interim coverage estimates do not include catch-up doses delivered by general practitioners or persons who were vaccinated prior to the onset of the program. Therefore, these data should be considered minimum estimates of coverage. The 1st year of the school-based HPV vaccination program should be considered a success, given time and resource constraints. Public sector immunisation providers across Australia should be commended for planning and implementing a new national immunisation program in approximately 4 months.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19374275

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  31 in total

1.  Improving human papillomavirus vaccine delivery: a national study of parents and their adolescent sons.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Kim Chantala; Noel T Brewer
Journal:  J Adolesc Health       Date:  2012-03-15       Impact factor: 5.012

2.  Default policies and parents' consent for school-located HPV vaccination.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Noel T Brewer
Journal:  J Behav Med       Date:  2012-01-21

3.  Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs.

Authors:  Jessica A Nodulman; Randall Starling; Alberta S Kong; David B Buller; Cosette M Wheeler; W Gill Woodall
Journal:  J Sch Health       Date:  2015-05       Impact factor: 2.118

Review 4.  The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Authors:  Terri B Hyde; Holly Dentz; Susan A Wang; Helen E Burchett; Sandra Mounier-Jack; Carsten F Mantel
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

5.  HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland.

Authors:  Emilien Jeannot; Philippe Sudre; Philippe Chastonay
Journal:  Int J Public Health       Date:  2012-02-28       Impact factor: 3.380

6.  HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff.

Authors:  Paul L Reiter; Brenda Stubbs; Catherine A Panozzo; Dianne Whitesell; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-23       Impact factor: 4.254

7.  HPV vaccine and adolescent males.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica A Kadis; Noel T Brewer
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

8.  Opportunities for increasing human papillomavirus vaccine provision in school health centers.

Authors:  Jennifer L Moss; Ashley L Feld; Brittany O'Malley; Pamela Entzel; Jennifer S Smith; Melissa B Gilkey; Noel T Brewer
Journal:  J Sch Health       Date:  2014-06       Impact factor: 2.118

9.  A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study.

Authors:  L Brabin; S A Roberts; R Stretch; D Baxter; P Elton; H Kitchener; R McCann
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

10.  Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

Authors:  J Cuzick; A Castañón; P Sasieni
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.